You are viewing: Other Countries ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The Other Countries ECMO Machines Market was valued at $13.05 Million in 2025 and projected to reach to $17.3 Million by 2030, representing a compound annual growth rate of 5.8%. Rest Of Latin America's ECMO machines market is poised for steady growth through 2030, driven by expanding critical care infrastructure and increasing recognition of extracorporeal membrane oxygenation as a vital therapeutic option.

Other Countries ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Other Countries ECMO Machines Market Trends and Insights

  • Rest Of Latin America is experiencing steady adoption of extracorporeal membrane oxygenation technology, driven by increasing critical care infrastructure investments and rising prevalence of cardiopulmonary diseases.
  • The region's healthcare systems in Rest Of Latin America are gradually modernizing, with hospitals expanding their intensive care units and acquiring advanced life support equipment to meet growing patient demand. Rest Of Latin America's ECMO market growth is supported by improving healthcare spending and greater awareness of ECMO's clinical benefits in treating severe respiratory and cardiac conditions.
  • Rest Of Latin America's smaller patient populations and developing healthcare networks present both challenges and opportunities for market expansion through 2030.
  • Key regional players and international manufacturers are increasingly targeting Rest Of Latin America with tailored solutions and training programs to enhance market penetration..

Key Market Statistics

  • CAGR (2025-2030) 5.8% CAGR
  • Market Size, 2025 ~USD 13.05 Million
  • Forecast, 2030 ~USD 17.3 Million
  • Country Other Countries

Other Countries ECMO Machines Market Overview

Market Size & Growth :

Rest Of Latin America's ECMO machines market is valued at USD 13.05 million in 2025, with projected growth to USD 17.30 million by 2030, reflecting a steady 5.8% CAGR aligned with global expansion trends.

Critical Care Infrastructure Expansion :

Increasing investments in critical care infrastructure across Rest Of Latin America are driving ECMO technology adoption, with hospitals upgrading intensive care units to support advanced cardiopulmonary support capabilities.

Rising Cardiovascular Disease Burden :

Growing prevalence of cardiac and respiratory conditions in Rest Of Latin America is creating sustained demand for extracorporeal membrane oxygenation solutions as a life-saving intervention for critically ill patients.

Regional Healthcare Modernization :

Healthcare systems in Rest Of Latin America are modernizing treatment protocols and adopting advanced technologies, positioning ECMO machines as essential equipment in tertiary care centers and specialized cardiac facilities.

Other Countries ECMO Machines Market Dynamics

  • Healthcare institutions across the region are prioritizing investments in advanced life support technologies to address rising cardiovascular and respiratory disease burdens.
  • The 5.8% CAGR reflects gradual but consistent market penetration as hospitals enhance their intensive care capabilities and clinical expertise in ECMO management. Market expansion in Rest Of Latin America will be supported by improving healthcare financing, growing medical device accessibility, and enhanced clinical training programs.
  • Regional manufacturers and distributors are establishing stronger supply chains, while international companies are increasing market presence through partnerships with local healthcare providers.
  • These developments position Rest Of Latin America as an emerging market with significant growth potential in the ECMO segment over the forecast period..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Rest Of Latin America's ECMO machines market is valued at USD 13.05 million in 2025 and will reach USD 17.30 million by 2030 at a 5.8% CAGR.
    • Rest Of Latin America is witnessing increased adoption of ECMO technology due to expanding critical care infrastructure and rising cardiopulmonary disease prevalence.
    • Rest Of Latin America's healthcare modernization efforts and improved spending are key drivers supporting market growth through the forecast period.
    • Rest Of Latin America presents emerging opportunities for international manufacturers through targeted training programs and localized solutions.

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    Other Countries ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    Target Audience

    • Medical Device Manufacturers : ECMO equipment producers need Rest Of Latin America-specific market data to assess regional demand, plan product launches, and optimize manufacturing and distribution strategies for this emerging market.
    • Healthcare Investors & PE Firms : Investment professionals require detailed market analysis of Rest Of Latin America's ECMO segment to evaluate growth potential, identify acquisition targets, and make informed capital allocation decisions.
    • Hospital & Healthcare Administrators : Critical care facility leaders in Rest Of Latin America need market insights to justify ECMO equipment investments, benchmark against regional peers, and plan intensive care unit modernization initiatives.
    • Medical Device Distributors & Suppliers : Regional distributors require Rest Of Latin America-specific market intelligence to identify growth opportunities, negotiate supplier agreements, and develop effective sales strategies for ECMO products.
    • Healthcare Consultants & Analysts : Industry consultants and research professionals need comprehensive Rest Of Latin America market data to support client advisory services, competitive analysis, and strategic planning recommendations.

    Key Companies in the Other Countries ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    Reasons to Buy this Report

    • Region-Specific Market Sizing : Obtain precise market valuation and growth projections exclusive to Rest Of Latin America, enabling accurate financial forecasting and resource allocation for regional expansion strategies.
    • Competitive Landscape Intelligence : Understand market dynamics, key players, and competitive positioning within Rest Of Latin America's ECMO segment to identify partnership and investment opportunities.
    • Infrastructure Investment Insights : Access detailed analysis of critical care infrastructure development across Rest Of Latin America, revealing high-potential markets and facility upgrade cycles driving ECMO demand.
    • Clinical Adoption Drivers : Gain actionable insights into disease prevalence, clinical protocols, and healthcare modernization initiatives specific to Rest Of Latin America that influence ECMO technology adoption.
    • Strategic Market Entry Planning : Leverage region-specific data to develop targeted go-to-market strategies, identify distribution channels, and establish partnerships aligned with Rest Of Latin America's healthcare ecosystem.

    Frequently asked questions

    What is the market size of ECMO machines in Rest Of Latin America?

    Rest Of Latin America's ECMO machines market is estimated at USD 13.05 million in 2025 and is projected to reach USD 17.30 million by 2030.

    What is the growth rate of the ECMO market in Rest Of Latin America?

    Rest Of Latin America's ECMO machines market is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2030.

    What factors are driving ECMO adoption in Rest Of Latin America?

    Rest Of Latin America's ECMO market growth is driven by increasing critical care infrastructure investments, rising cardiopulmonary disease prevalence, healthcare modernization, and improved clinical awareness of ECMO benefits.

    What challenges does the ECMO market face in Rest Of Latin America?

    Rest Of Latin America faces challenges including smaller patient populations, developing healthcare networks, limited specialized training resources, and varying healthcare spending levels across the region.

    What opportunities exist for ECMO manufacturers in Rest Of Latin America?

    Rest Of Latin America offers opportunities through healthcare system modernization, expanding intensive care units, partnerships with regional hospitals, and development of cost-effective ECMO solutions tailored to local needs.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status